Nelson v. Bayer Healthcare Pharmaceuticals Inc. et al
Filing
12
OPINION AND ORDER GRANTING 10 MOTION (Joint) to Stay All Proceedings by Defendant Bayer Healthcare Pharmaceuticals Inc. The proceedings in this action are STAYED until the MDL determination is entered. Parties ORDERED to provide the Court with timely notice of any decision by the MDL Panel regarding the transfer of the instant matter. Signed by Magistrate Judge Susan L Collins on 8/31/15. (cer)
UNITED STATES FEDERAL COURT
NORTHERN DISTRICT OF INDIANA
FORT WAYNE DIVISION
NICOLE NELSON,
Plaintiff,
v.
BAYER HEALTHCARE
PHARMACEUTICALS, INC., et al.,
Defendants.
)
)
)
)
)
)
)
)
)
)
Cause No. 1:15-cv-00172-JTM-SLC
OPINION AND ORDER
Before the Court in this product liability case is a Joint Motion to Stay All Proceedings
(DE 10) filed on August 24, 2015, by Plaintiff Nicole Nelson and Defendant Bayer Healthcare
Pharmaceuticals pursuant to Federal Rule of Civil Procedure 6(b). In the motion, Nelson and
Bayer request that the Court stay all proceedings in this case pending transfer of this action,
pursuant to 28 U.S.C. § 1407, to a multidistrict litigation, In re: Mirena IUD Products Liability
Litigation, MDL No. 2434, in the United States District Court for the Southern District of New
York (“MDL-2434”). (DE 10). Defendants Bayer Oy and Bayer Pharma AG have not yet
appeared in this action.
As background, Nelson filed this product liability action against Defendants on July 3,
2015. (DE 1). The case concerns the alleged risks of uterine perforation and migration
associated with the Mirena® intra-uterine contraceptive and the adequacy of the U.S. Food and
Drug Administration approved product warnings. Also pending against Defendants are cases in
other jurisdictions purportedly involving similar factual allegations, common questions of law
and fact, and overlapping claims for relief. (DE 11 at 1-2). Bayer submitted this action to the
Judicial Panel on Multidistrict Litigation as a “tag-along” for transfer to MDL-2434, and the
parties expect that transfer of this case will be completed promptly.
“[T]he power to stay proceedings is incidental to the power inherent in every court to
control the disposition of the causes on its docket with economy of time and effort for itself, for
counsel, and for litigants.” Pfizer Inc. v. Apotex Inc., 640 F. Supp. 2d 1006, 1007 (N.D. Ill. 2009
(quoting Landis v. N. Am. Co., 299 U.S. 248, 254 (1936)). “In the context of multidistrict
litigation, when a party submits a motion to the MDL Panel for transfer and consolidation, a
court may exercise its discretion to stay discovery, postpone ruling on pending motions or
generally suspend further rulings.” Azar v. Merck & Co., Inc., No. 3:06-cv-0579 AS, 2006 WL
3086943, at *1 (N.D. Ind. Oct. 27, 2006) (citing Rivers v. Walt Disney Co., 980 F. Supp. 1358
(C.D. Cal. 1997); Manual for Complex Litig. § 20.131 (4th ed. 2004)). “When considering a
motion to stay in this context, courts consider three factors: (1) potential prejudice to the
non-moving party; (2) hardship and inequity to the moving party if the action is not stayed; and
(3) the judicial resources that would be saved by avoiding duplicative litigation if the cases are in
fact consolidated.” Id. (citing Rivers, 980 F. Supp at 1360). “The interest of judicial economy is
often best served by staying preliminary pretrial proceedings while a motion to transfer and
consolidate is pending with the MDL Panel.” Id. (citing Rivers, 980 F. Supp. at 1362).
Here, Nelson and Bayer jointly request the stay, and thus, there is no suggestion that a
stay would prejudice either party. A stay will conserve judicial resources by avoiding
duplicative litigation of common issues, and it also may prevent inconsistent rulings on the
common issues. A decision on whether this case will be transferred to the MDL is expected
shortly, and thus, the stay will not excessively delay this matter. Accordingly, the Court finds
2
that granting the requested stay will facilitate a just and expeditious resolution of this action.
See, e.g., Estate of Ronald Hoholek v. Abbvie, Inc., No. 2:14-CV-405, 2014 WL 7205586, at *3
(N.D. Ind. Dec. 17, 2014) (granting a motion to stay pending transfer to an MDL); Benge v. Eli
Lilly & Co., 553 F. Supp. 2d 1049, 1050-51 (N.D. Ind. 2008) (same); Anderson v. Eli Lilly &
Co., No. 4:08-CV-00014-AS-PRC, 2008 WL 1776470, at *1-2 (N.D. Ind. Apr. 16, 2008) (same);
Azar, 2006 WL 3086943, at *1-2 (same).
The Joint Motion to Stay All Proceedings (DE 10) is GRANTED, and the proceedings in
this action are STAYED until the MDL determination is entered. The Court ORDERS the
parties to provide the Court with timely notice of any decision by the MDL Panel regarding the
transfer of the instant matter.
SO ORDERED.
Entered this 31st day of August 2015.
S/ Susan Collins
Susan Collins
United States Magistrate Judge
3
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?